Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.68 -0.01 (-0.21%)
As of: Sep 30, 2026 · 11:54 AM EDT

Oramed Pharmaceuticals (ORMP) EV to CFO (2016 - 2017)

Updated

Oramed Pharmaceuticals' (ORMP) EV to CFO stood at 34.35 in Q3 2017, up 43.6% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) EV to CFO (2016 - 2017) Analysis & Trends

On a TTM basis, Oramed Pharmaceuticals' EV to CFO came in at 28.46 as of May 31, 2017; for FY2016, it was 18.97.

  • Per Business Quant, the preceding three quarters came in at 23.91 (Q2 2017), 8.99 (Q1 2017) and 18.97 (Q4 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Oramed Pharmaceuticals 196.24 Mn 196.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2017 34.35
Feb 28, 2017 23.91
Nov 30, 2016 8.99
Aug 31, 2016 18.97
API Access

Oramed Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=ORMP&period=max&api_key=YOUR_API_KEY